BBB National Programs Decision Summaries
BBB National Programs provides summaries of all case decisions from the National Advertising Division (NAD), National Advertising Review Board (NARB), Children’s Advertising Review Unit (CARU), Direct Selling Self-Regulatory Council (DSSRC), and Digital Advertising Accountability Program (DAAP). Subscribe to receive a weekly wrap-up of published case decisions in your inbox.
- All
-
12/09/2017 - NAD Recommends Behavioral Technology Group Discontinue Advertising Claims for ‘Pavlok’ Aversion Therapy Wristband
The National Advertising Division has recommended that Behavioral Technology Group, Inc., discontinue all challenged advertising claims for the company’s “Pavlok” device, a wristband that the company said was designed to help users break “bad habits” through the administration of an electric stimulus. -
12/07/2017 - NAD Recommends BA Sports Nutrition Halt Certain Claims for ‘BodyArmor,’ Finds Certain Claims Supported; Advertiser Voluntarily Discontinues Certain Claims
The National Advertising Division has recommended that BA Sports Nutrition, maker of BodyArmor sports drinks, discontinue certain advertising claims challenged by Stokely-Van Camp, Inc., the maker of competing Gatorade sports drinks. NAD determined that certain claims made by the advertising were supported and certain claims were voluntarily discontinued by the advertiser. -
12/04/2017 - NAD Reviews Claims made by Nest Labs for its ‘Learning Thermostat,’ Finds Advertiser Can Support Claims at Issue
The National Advertising Division had determined that Nest Labs, Inc., can support the claims made in a print ad that ran in the New York Times. -
12/02/2017 - NAD Recommends Bausch & Lomb Discontinue Challenged Superiority Claims for ‘PeroxiClear Contact Lens Solution,’ Finds Company Can Support Certain Claims
The National Advertising Division has recommended that Bausch & Lomb, Inc., maker of PeroxiClear Contact Lens Peroxide Solution, modify or discontinue certain advertising claims, including claims of superior comfort over Clear Care, a competing product manufactured by Alcon Laboratories, Inc. -
11/30/2017 - CARU Recommends Subway Better Disclose Material Information in Advertising Sweepstakes to Children; Company Agrees to Do So
The Children’s Advertising Review Unit has recommended that Subway, when advertising sweepstakes to children, more clearly disclose material information and avoid undue sales pressure. -
11/20/2017 - NARB Recommends Shell Modify, Discontinue Certain Claims for Shell V-Power NiTRO+ Premium Gasoline
A panel of the National Advertising Review Board has recommended that Shell Oil Company modify or discontinue certain challenged claims for the company’s Shell V-Power NiTRO+ Premium Gasoline (SVPN+), including claims that SVPN+ provides the best total engine protection consumers can get. -
11/14/2017 - Beech-Nut Says It Has Permanently Discontinued Claims Challenged by Nestle, Maker of Gerber Products
The Beech-Nut Nutrition Company has said it will discontinue all advertising claims challenged by Nestle Nutrition U.S. before the National Advertising Division. Nestle, maker of Gerber infant foods, challenged claims made in advertising for Beech-Nut infant cereal products. -
11/13/2017 - NARB Recommends Unilever Discontinue Claims Made in Video, Packaging that Reference Bath & Body Works Products
A panel of the National Advertising Review Board (NARB) has recommended that Unilever United States Inc., discontinue preference and parity claims made in advertising for Suave body wash that reference Bath & Body Works products. -
11/08/2017 - NAD Recommends Too Faced Cosmetics Discontinue ‘1,944% More Volume’ Claim for Better Than Sex Mascara, Advertiser to Appeal
The National Advertising Division has recommended that Too Faced Cosmetics, LLC, discontinue the “1,944% more volume” claim – and before and after photographs – made on product packaging and online videos for the company’s Better Than Sex original and waterproof mascara. The company said it will appeal NAD’s decision. -
11/08/2017 - NAD Refers Claims Made by Synergy to FTC After Pharma Company Declines to Participate; Claims Challenged by Allergan
The National Advertising Division has referred advertising claims made Synergy Pharmaceuticals, Inc., to the Federal Trade Commission after the advertiser declined to participate in a proceeding before NAD.